PMOS Research Observatory

Explore PMOS Research

Search 20,708 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.

20,708 articles match

Total citations

289,983

Peak year

2025(3,021 articles)

Avg citations / article

14

Publications per year

All countries

Topics

All research areas ⓘ

Endocrinology & Hormones12,848
Metabolic Health10,508
Fertility & Reproduction6,468
Epidemiology & Public Health3,913
Pharmacology & Treatment2,800
Genetics & Genomics2,441
Diagnostics & Phenotyping2,345
Mental Health & Psychology1,933

Countries

All countries

China3,806
United States2,435
India1,743
Iran1,194
Turkey922
United Kingdom754
Australia615
Italy475

Top journals

All filters

Fertility and Sterility584
Endocrine Abstracts510
Gynecological Endocrinology400
Frontiers in Endocrinology369
Figshare340
Journal of the Endocrine Society328
Human Reproduction275
Research Square (Research Square)270
PubMed258
The Journal of Clinical Endocrinology & Metabolism223

Top institutions

All filters

Monash University323
Tehran University of Medical Sciences234
Shanghai Jiao Tong University228
Shahid Beheshti University of Medical Sciences221
Peking University212
Shandong University177
Karolinska Institutet167
Peking University Third Hospital166
Monash Health165
University of Adelaide156

Where in the world is each topic being researched?

Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.

HormonesMetabolicFertilityEpidemiol.PharmaGeneticsDiagnos.MentalNutritionMolecularCell BioInflamm.LifestyleMicrobiomeDermatol.
China1.00.91.01.01.11.60.60.31.01.92.01.10.51.60.1
United States1.01.11.11.30.80.91.11.40.50.70.60.71.20.71.3
India0.90.90.90.90.91.12.11.11.30.80.60.80.90.91.8
Iran1.00.90.90.91.60.70.51.11.90.71.02.00.80.70.8
Turkey1.31.20.90.60.40.51.40.90.70.50.61.60.41.11.7
United Kingdom0.91.00.91.31.00.70.92.10.80.60.40.72.00.41.3
Australia0.81.10.91.71.20.60.82.10.80.30.30.13.70.50.6
Italy1.11.21.00.80.90.51.10.81.40.40.30.61.01.11.6
Egypt1.00.81.90.52.00.30.90.60.80.60.41.10.40.21.7
Poland1.31.40.60.60.30.70.61.21.10.50.21.11.21.51.4
Under-specialised
Specialised|RCA > 1 = country focuses on this topic more than average

Studies20,381–20,400 of 20,708

All studies

Predictors of success of laparoscopic ovarian drilling in women with polycystic ovary syndrome: an evidence-based approach

2015Archives of Gynecology and Obstetrics3 citationsDOI ↗
Fertility & Reproduction

Primary and secondary prevention of metabolic and cardiovascular comorbidities in women with polycystic ovary syndrome

2015Revista Brasileira Ginecologia e Obstetrícia3 citationsDOI ↗
Endocrinology & HormonesFertility & ReproductionMetabolic Health

Serum Chemerin Levels In Polycystic Ovary Syndrome

2015Turkish Journal of Biochemistry3 citationsDOI ↗
Endocrinology & HormonesMetabolic HealthInsulin ResistanceObesity / Weight Gain

The Effect of Diet and Exercise in Women with Polycystic Ovary Syndrome

2015The FASEB Journal3 citationsDOI ↗
Endocrinology & HormonesLifestyle & ExerciseMetabolic HealthInsulin ResistanceObesity / Weight Gain

Effects of Letrozole in Prevention of Premature Luteinizing Hormone (LH) Surge in Infertile Women with Clomiphene Citrate Resistant Polycystic Ovary Syndrome (PCOS) Undergoing Intrauterine Insemination

2015Galen Medical Journal3 citationsDOI ↗
Endocrinology & HormonesFertility & Reproduction

Fasting Glucose Changes in Adolescents with Polycystic Ovary Syndrome Compared with Obese Controls: A Retrospective Cohort Study

2015Journal of Pediatric and Adolescent Gynecology3 citationsDOI ↗
Endocrinology & HormonesEpidemiology & Public HealthMetabolic HealthObesity / Weight Gain

Association of altered serum levels of Chemerin, Paraoxonase-1 (PON1), Asymmetric Dimethyl arginine (ADMA) and obesitin the development of Polycystic Ovarian Syndrome (PCOS) in Egyptian women

2015Indian Journal of Pharmaceutical and Biological Research3 citationsDOI ↗
Endocrinology & HormonesInflammation & Oxidative StressMetabolic HealthObesity / Weight Gain

Genetic Polymorphism of CYP1A1 (T6235C) Gene as a Risk Factor for Polycystic Ovary Syndrome

2015Andrology-Open Access3 citationsDOI ↗
Genetics & Genomics

Laparoscopic Sleeve Gastrectomy (LSG) as a Therapeutic Strategy for the Management of Polycystic Ovarian Syndrome (PCOS) in Obese Patients

2015Canadian Journal of Diabetes3 citationsDOI ↗
Endocrinology & HormonesFertility & ReproductionMetabolic HealthObesity / Weight Gain

Anti-Müllerian Hormone Serum Measurements Reflect Cycle Length and Ovarian Follicle Number in Women With Polycystic Ovary Syndrome [350]

2015Obstetrics and Gynecology3 citationsDOI ↗
Diagnostics & PhenotypingEndocrinology & HormonesFertility & ReproductionAcneHirsutism

Elevated thrombin activatable fibrinolysis inhibitor levels in women with polycystic ovary syndrome

2015Gynecological Endocrinology3 citationsDOI ↗
Endocrinology & HormonesMetabolic HealthCardiovascular Disease

220. Stellungnahme. Stellungnahme zum Einsatz von Metformin vor und während der Schwangerschaft bei Frauen mit PCOS und Kinderwunsch

2015Geburtshilfe und Frauenheilkunde3 citationsDOI ↗
Fertility & ReproductionPharmacology & Treatment

Clinical outcomes of three- or five-day treatment with clomiphene citrate combined with gonadotropins and a timed intercourse cycle in polycystic ovary syndrome patients

2015Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine3 citationsDOI ↗
Endocrinology & Hormones

54G/C polymorphism of SREBF-1 gene is associated with polycystic ovary syndrome

2015European Journal of Obstetrics & Gynecology and Reproductive Biology3 citationsDOI ↗
Endocrinology & HormonesGenetics & GenomicsMetabolic Health

A Comprehensive Disease Model of Polycystic Ovary Syndrome (Pcos)

2015Value in Health3 citationsDOI ↗
Endocrinology & HormonesMental Health & PsychologyMetabolic Health

Oxygen Hyperbaric Exposure Induces GLUT4 Expression Reduction and No Folliculogenesis Alterations in Rat PCOS with Insulin Resistance Model

2015Majalah Obstetri & Ginekologi3 citationsDOI ↗
Endocrinology & HormonesMetabolic HealthInsulin Resistance

Does the Use of Highly Purified Human Menopausal Gonadotrophin (HP-HMG) avoid Ovarian Hyperstimulation Syndrome (OHSS) in Polycystic Ovary (PCO) Patients in Assisted Reproduction (IVF/ICSI)?

2015Gynecology & Obstetrics3 citationsDOI ↗
Endocrinology & HormonesFertility & Reproduction

Is the association between insulin resistance and diabetogenic haematopoietically expressed homeobox (HHEX) polymorphism (rs1111875) affected by polycystic ovary syndrome status?

2015Reproduction Fertility and Development3 citationsDOI ↗
Endocrinology & HormonesGenetics & GenomicsMetabolic HealthInsulin Resistance

Inositol versus Metformin administration in polycystic ovary syndrome patients

2015Evidence Based Women s Health Journal3 citationsDOI ↗
Fertility & ReproductionMetabolic HealthNutrition & DietInsulin Resistance

PCOS Therapy

20153 citationsDOI ↗
Pharmacology & Treatment
← Prev…10181019102010211022…Next →